Mechanistically, CagA hinders CD8+ T cell proliferation and anti-cancer responses by enhancing PD-L1 levels in exosomes from gastric cancer cells through p53 and miRNA-34a inhibition. This evidence concerns the gene S100A8 and gastric cancer.